skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


No Subject Data
238 Daewoong Pharmaceutical’s ‘Daewoong Infion’ receives Minister of Health and Welfare Award in Indonesia 2017-11-14
237 Daewoong Pharmaceutical’s NABOTA registered US adopted name.. A gradual preparation to enter US market 2017-11-06
236 Daewoong Pharmaceutical’s Erdos is the only expectorant proved to reduce COPD exacerbation period 2017-10-18
235 Daewoong Pharmaceutical built 2nd plant for Nabota with annual capacity of 4.5 million vials for international expansion 2017-10-10
234 Daewoong Pharmaceutical entered into 5 collaborative research contracts with China’s Shenyang University of Pharmaceutical and to build Daewoong Research Center within the university 2017-04-05
233 Daewoong Pharmaceutical’s Osong Plant introduced its state-of-the-art production facilities to high government officials on health and medicine from Central and South America 2017-04-04
232 Daewoong Pharmaceutical seeks to build industry-university-government network in Biomecca Indonesia for an open collaboration opportunity 2017-03-27
231 Nabota, Daewoong Pharmaceutical’s botulinum toxin, enters markets in Middle East and Vietnam 2017-03-20
230 Daewoong Pharmaceutical ‘Daewoong Infion’ receives Most Outstanding Pharmaceutical Company Award in Indonesia 2017-03-17
229 Daewoong Pharmaceutical’s India Research Center sets its vision as the global RA hub 2017-03-09
first page previous page 1  / 2  / 3  / 4  / 5  / 6  / 7  / 8  / 9  / 10  / next page last page